I Patients with pernicious anaemia Parameters used for studying this group included the following: full blood count; serum vitamin B12 level (Lactobacillus leichmanii); serum folate level (Lactobacillus casei); augmented histamine test meal (in most patients); sternal marrow examination; and antibodies to gastric parietal cells and intrinsic factor (not examined in all patients).
These were all assessed before the Schilling test was performed. Table I shows the haemoglobin values at the time of diagnosis and indicates that many of the patients were only slightly anaemic. One patient (J.S., Table I Table I shows the distribution of our data for urine and serum in patients with pernicious anaemia (for part 1 and for part 2 with intrinsic factor). In part 1 of the test the mean values for the urine excretion of 57Co vitamin B12 were significantly lower than normal, and similarly for the serum levels, usually rising to normal levels when the test was repeated with the addi- Table II shows the data for this group of patients. The mean for urine and serum is seen to be higher than for normal controls. Table III shows the urine and serum levels of 57Co vitamin B12 for these patients. Table III ) who had levels of 5-8 g/100 ml and 7-4 g/100 ml respectively.
STUDIES ON PATIENTS AFTER PARTIAL GASTRECTOMY
The data for this group of patients are given in Table IV . Parts 1 and 2 of the Schilling test were performed in each case except for the last patient in the list (R.D., Table IV ). Table V shows that there are no significant differences between the first and second parts of the test, either for urine or serum if the results are taken together, but individually it is seen that both R.S. and A.B. (Table IV) showed a significant rise. However, patients W.C. and A.W. both showed a fall in the second part of the test. Discussion Table I shows that there was clear demarcation between the part 1 Schilling test results (urine and serum levels) for patients with pernicious anaemia (including those with no evidence of anaemia) and those of normal controls, and that there was no overlap between the two groups, confirming the observations of many previous workers.
One patient (D.T., Table I ) failed to show a rise in the urinary excretion of 57Co vitamin B12 when intrinsic factor was given. This may be in keeping with the observations of several investigators that there is sometimes a malabsorption for vitamin B12 in patients who have suffered deficiency of the vitamin for a considerable time (Haurani, Sherwood, and Goldstein, 1964; Brody, Estren, and Herbert, 1966; Carmel and Herbert, 1967) . These authors have demonstrated that this specific malabsorption is reversible when patients are treated with vitamin B12, and they showed that the Schilling test part 2 became normal after periods ranging from one to 20 months. Some of the patients had only been reinvestigated after an elapse of several months or more, and it is therefore possible that the time of response may have been considerably shorter. Goldberg, Bickel, and Fudenberg (1969) Table V ).
The five patients in the hypopituitary group all showed a urinary excretion of 57Co vitamin B12 greater than 20-0%. Two of the patients had excretions greater than the upper limit of the normal range (using 95 % confidence limits). In addition, two of the three remaining patients had serum levels of 57Co vitamin B12 in excess of the normal range. Hence, four of the five patients would have been separable from the normal controls taking either the urine or serum values alone as significant.
From Table II it is noted that the highest two urinary excretions belonged to patients who were not receiving replacement therapy at the time of the test (W.M. and S.S., Table II ). However, the excretion in the third patient not receiving therapy was lower than these, although the eighthour serum level was the highest of the group.
It is possible that the physiological mechanism for this increased excretion of vitamin B12 in hypopituitarism is in some way related to deficiency of certain hormonal factors, either the trophic hormones produced by the pituitary, or deficient production of hormones by the target organs for these trophic hormones, namely, the thyroid, adrenals, and the gonads.
Also to be considered is the possibility that the adenomatous tissue of the pituitary tumours themselves may be producing a substance which has an effect on vitamin B12 metabolism. It is hoped that further work will establish whether or not pituitary adenomas are the necessary factor, or whether hypopituitarism per se, whatever its cause, will produce the same effect.
It is established in humans that the thyroid gland influences xylose metabolism. Broitman, Bondy, Yachnin, Hoskins, Ingbar, and Zamcheck (1964) showed that although the absorption of xylose was normal in states of thyrotoxicosis and myxoedema, the urinary excretion was low in myxoedema and increased in hyperthyroidism. Furthermore, they showed that the excretory pattern was similar when the xylose was given intravenously. They calculated that there was a decreased rate of renal clearance and an apparently normal rate of extrarenal disposal in patients with myxoedema, and that there was a decreased rate of extrarenal disposal with a concomitant increase in renal excretion in patients with hyperthyroidism.
Also of importance in this connexion are experiments involving the use of rats in which there was shown to be increased absorption of vitamin B12 when the animals were fed on large doses of desiccated thyroid together with a casein-containing diet, and a decreased absorption of the vitamin when the animals were thyroidectomized (Okuda, Steelman, and Chow, 1956) .
It would appear, however, that these animal experiments were in conflict with our findings in hypopituitary patients if the thyroid were the factor responsible for the difference from the normal controls. One might thus expect a lowered excretion of vitamin B12 if there was a degree of hypothyroidism secondary to hypopituitarism, instead of the increase observed. On the other hand, the aetiology of the hypothyroidism is different in the two examples, and this fact may be of importance in the interpretation of the results. The hypothyroidism of pituitary insufficiency is mediated through the pituitary, whereas that of the hypothyroid rats was induced by excision of the thyroid gland, in which case the pituitary gland in each animal of the series was intact. Experiments on vitamin B12 absorption in patients with thyrotoxicosis and myxoedema are in progress.
The question arises whether the thyroid could have an effect on overall vitamin B12 metabolism, or simply on transport across the intestinal mucosa. Thus it is established that the intracellular accumulation in vitro of the amino acids cycloleucine, histidine, and valine, and the sugar a.-methyl-D-glucopyranoside, were increased in the intestinal segments of rats made hypothyroid by thyroidectomy and radioactive 1311 (London and Segal, 1967) . When the hypothyroid animals were treated with triiodo-Vitamin B12 absorption in some neurological and neuroendocrine disorders thyronine the accumulation of substrate fell toward the control level. The authors suggested that as this phenomenon was seen with an unutilizable amino acid and sugar, it strongly suggested an effect on transport rather than on metabolism.
So far we have considered only the hypothyroid element of the hypopituitary state. Another possible explanation to be considered is that the replacement therapy itself may be responsible for the increased vitamin B12 absorption in the hypopituitary group. That this is not tenable is shown by the fact that three of the five patients were, at the time of the Schilling test, not on any form of therapy.
There is known to be an increased incidence of pernicious anaemia in myxoedema (Leithold, David, and Best, 1958; Forssell and Halunen, 1958; Ardeman, Chanarin, Krafchik, and Singer, 1966; and Strickland, 1969) , and also of low serum vitamin B12 levels in hypothyroidism without pernicious anaemia (Tudhope and Wilson, 1962) . Again this observation does not account for our hypopituitary observations. Ziffer, Gutman, Pasher, Sobotka, and Baker (1957) , however, demonstrated that the whole-blood vitamin B12 values were lower in a group of hyperthyroid patients than in a normal control group and a myxoedematous group. The mean urinary excretion after the vitamin B12 dose was considerably lower in hyperthyroid patients than in the normal group, and the myxoedematous group showed an increased excretion. These authors suggested that vitamin B12 turnover and demand is greater in hyperthyroid patients and lower in myxoedema.
There have been reports of pernicious anaemia in Addison's disease (Berlin, 1952; Strickland, 1969) (Vilter, 1964) . This can be-seen by the changes in serum levels of the one in-response to changes in serum levels of the other: for example, the tendency to high serum folate levels in pernicious anaemia (Waters and Mollin, 1961; Waters and Mollin, 1962; Waters and Mollin, 1963) , and the reduction in the serum vitamin B12 in epileptic patients who are treated with folic acid for folate deficiency induced by anticonvulsant therapy (Hunter, Barnes, and Matthews, 1969) .
It was with these facts in mind that Schilling tests were done on a series of folate-deficient epileptic patients who had been treated with various combinations of the drugs mentioned above. Lees (1961) reported that the Schilling test indicated a lower absorption of vitamin B12
in patients who had developed megaloblastic anaemia while on anticonvulsant drugs, and that in six of eight patients a considerable increase occurred when folic acid therapy was given.
In our series, however, there was no significant difference (see Table V ) between the series of normal controls and the epileptic patients who were folate deficient. Only two of our series of 10 patients had a significant anaemia, and the explanation of the disparity between our results and those of Lees may lie here.
As shown in Tables III and V , there is no significant difference for the urine and serum levels of 57Co vitamin B12 in the Schilling test between the folate-deficient epileptic patients and the series of normal controls. Table IV illustrates the importance of studying individual patients separately, as certain changes between part 1 and 2 tests do not show up when the group is studied as a whole.
It should be noted that none of these patients was given a vitamin B12-free meal at the time the radioactive vitamin B12 was given in the Schilling test. Deller, Germar, and Witts (1961) noted that when a vitamin B12-free meal was given with the labelled vitamin B12 in the Schilling test absorption was significantly enhanced in patients who had undergone partial gastrectomy. Turnbull (1967) observed similar results in a series of patients with anaemia after Polya partial gastrectomy, and suggested that the improved absorption of vitamin B12 with food was likely to be due to stimulation of a small residual secretion of intrinsic factor.
These initial findings by the more precisely standardized Schilling test counting both urine and serum radioactivity confirm and extend the observations of others. The explanations for the mechanism of increased excretion of radioactive vitamin B12 in patients with pituitary tumours and the fall in excretion in part 2 in some postgastrectomy patients with neurological complications are not at present apparent and clearly need further investigation.
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